Owl Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Investors
  • 1

Owl Therapeutics General Information

Description

Developer of degenerative artificial intelligence and biomarker-powered therapeutics to enhance and protect microglia to clear brain cell debris. The company specializes in brain health and traumatic brain injury management and leverages artificial intelligence to create a diversified pipeline of small and large-molecule medicines, including therapeutic monoclonal antibodies and fusion proteins, aimed at accelerating the clearance of brain cell debris and limiting inflammation, enabling the healthcare sector to address unmet needs of patients with traumatic brain injury and related conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 255 Main Street
  • Suite 200
  • Cambridge, MA 02142
  • United States
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Pharmaceuticals
Corporate Office
  • 255 Main Street
  • Suite 200
  • Cambridge, MA 02142
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Owl Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 10-Jun-2025 Cancelled Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Spin-Off 15-May-2023 Completed Generating Revenue
To view Owl Therapeutics’s complete valuation and funding history, request access »

Owl Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Owl Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
5 Horizons Capital Venture Capital Minority
To view Owl Therapeutics’s complete investors history, request access »

Owl Therapeutics FAQs

  • When was Owl Therapeutics founded?

    Owl Therapeutics was founded in 2023.

  • Where is Owl Therapeutics headquartered?

    Owl Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Owl Therapeutics?

    Owl Therapeutics has 5 total employees.

  • What industry is Owl Therapeutics in?

    Owl Therapeutics’s primary industry is Drug Discovery.

  • Is Owl Therapeutics a private or public company?

    Owl Therapeutics is a Private company.

  • What is Owl Therapeutics’s current revenue?

    The current revenue for Owl Therapeutics is .

  • Who are Owl Therapeutics’s investors?

    5 Horizons Capital has invested in Owl Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process